These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20055125)

  • 1. [Advances in the study of regulation of novel organic cation transporter-2].
    Wang FR; Guo RC
    Yao Xue Xue Bao; 2009 Oct; 44(10):1061-5. PubMed ID: 20055125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
    Ringseis R; Pösel S; Hirche F; Eder K
    Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species.
    Ringseis R; Luci S; Spielmann J; Kluge H; Fischer M; Geissler S; Wen G; Hirche F; Eder K
    Eur J Pharmacol; 2008 Mar; 583(1):11-7. PubMed ID: 18258227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
    Zhou X; Wen G; Ringseis R; Eder K
    J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats.
    Ringseis R; Lüdi S; Hirche F; Eder K
    Pharmacol Res; 2008 Jul; 58(1):58-64. PubMed ID: 18620058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues.
    Luci S; Hirche F; Eder K
    Ann Nutr Metab; 2008; 52(1):58-67. PubMed ID: 18309235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
    Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
    Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
    Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
    Sugiura T; Kato Y; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):375-83. PubMed ID: 17072090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
    D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
    J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
    Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
    J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pro-inflammatory cytokine tumor necrosis factor α stimulates expression of the carnitine transporter OCTN2 (novel organic cation transporter 2) and carnitine uptake via nuclear factor-κB in Madin-Darby bovine kidney cells.
    Zhou X; Ringseis R; Wen G; Eder K
    J Dairy Sci; 2015 Jun; 98(6):3840-8. PubMed ID: 25892691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
    Koch A; König B; Stangl GI; Eder K
    Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
    Amat di San Filippo C; Longo N
    J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic polyrotaxanes effectively inhibit uptake via carnitine/organic cationic transporters without cytotoxicity.
    Utsunomiya H; Katoono R; Yui N; Sugiura T; Kubo Y; Kato Y; Tsuji A
    Macromol Biosci; 2008 Jul; 8(7):665-9. PubMed ID: 18366149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine transport by organic cation transporters and systemic carnitine deficiency.
    Lahjouji K; Mitchell GA; Qureshi IA
    Mol Genet Metab; 2001 Aug; 73(4):287-97. PubMed ID: 11509010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Okura T; Kato S; Deguchi Y
    Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
    Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.